Statera Biopharma Inc
(STAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 671 | 769 | 998 | 1,251 | 237 |
| Cost of Goods | 169 | 201 | 354 | 372 | 116 |
| Gross Profit | 501 | 568 | 644 | 878 | 121 |
| Operating Expenses | 2,217 | 3,622 | 7,611 | 78,433 | 9,881 |
| Operating Income | -1,546 | -2,854 | -6,614 | -77,182 | -9,644 |
| Interest Expense | 1,811 | 637 | 1,146 | 0 | 3,089 |
| Other Income | 0 | 0 | 0 | -68 | 0 |
| Pre-tax Income | -3,357 | -3,491 | -7,760 | -77,250 | -12,733 |
| Net Income Continuous | -3,357 | -3,491 | -7,760 | -77,250 | -12,733 |
| Minority Interests | -8 | -3 | -3 | -11 | -13 |
| Net Income | $-3,349 | $-3,487 | $-7,757 | $-77,239 | $-12,720 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.20 | -1.94 | -0.47 |
| EPS Basic Continuous Ops | -0.07 | -0.07 | -0.20 | -1.95 | -0.47 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.20 | -1.94 | -0.47 |
| EPS Diluted Continuous Ops | -0.07 | -0.07 | -0.20 | -1.95 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -0.07 | N/A | N/A | N/A | -0.47 |
| EBITDA(a) | $-1,355 | $-2,722 | $-6,493 | $-77,069 | $-9,504 |